Lil­ly nabs in­jectable med­i­cines fa­cil­i­ty from Nexus Phar­ma

To help meet the height­ened de­mand for its in­jectable prod­ucts, Eli Lil­ly is ac­quir­ing a fa­cil­i­ty from Nexus Phar­ma­ceu­ti­cals, with pro­duc­tion an­tic­i­pat­ed to start at …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER